Seegene, Inc. (KOSDAQ:096530)
South Korea · Delayed Price · Currency is KRW 23,800
-200 (-0.83%)
At close: Dec 30, 2025
Seegene Market Cap
Seegene has a market cap or net worth of 1.1 trillion as of December 30, 2025. Its market cap has increased by 1.43% in one year.
Market Cap
1.10T
Enterprise Value
674.42B
Revenue
458.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
23,800.00
Market Cap Chart
Since September 10, 2010, Seegene's market cap has increased from 194.31B to 1.10T, an increase of 464.81%. That is a compound annual growth rate of 11.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 1.10T | 4.54% |
| Dec 30, 2024 | 1.05T | -1.30% |
| Dec 28, 2023 | 1.06T | -22.46% |
| Dec 29, 2022 | 1.37T | -56.39% |
| Dec 30, 2021 | 3.15T | -37.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.97T |
| Celltrion | 39.60T |
| ALTEOGEN | 24.04T |
| ABL Bio | 10.99T |
| SK Biopharmaceuticals | 9.83T |
| Yuhan | 8.39T |
| HLB Co., Ltd. | 6.69T |
| LigaChem Biosciences | 6.36T |